PAR 6.67% 24.0¢ paradigm biopharmaceuticals limited..

CHIKUNGUNYA - PEER REVIEWED !!!, page-22

  1. 285 Posts.
    lightbulb Created with Sketch. 82
    Eligible Diseases Under the Tropical Disease Priority Review Voucher System
    MalariaBlinding trachoma
    Buruli UlcerCholera
    Dengue/Dengue haemorrhagic feverDracunculiasis (guinea-worm disease)
    FascioliasisHuman African trypanosomiasis
    LeishmaniasisLeprosy
    Lymphatic filariasisOnchocerciasis
    SchistosomiasisSoil transmitted helminthiasis
    YawsTuberculosis
    Added by Congress
    Cueva virusEbola virus
    Marburg virusZika virus
    Added by FDA Order
    ChagasNeurocysticercosis
    Chikungunya Virus DiseaseLassa Fever
    RabiesCryptococcal Meningitis
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
0.015(6.67%)
Mkt cap ! $83.98M
Open High Low Value Volume
22.5¢ 24.0¢ 22.5¢ $173.6K 743.6K

Buyers (Bids)

No. Vol. Price($)
8 99346 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 131244 5
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.